Tomi Jun Selected Research

Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

10/2021

In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomi Jun Research Topics

Disease

10	Neoplasms (Cancer) 07/2023 - 11/2020
10	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2018
6	COVID-19 03/2022 - 11/2020
5	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 12/2021
5	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2020
3	Liver Diseases (Liver Disease) 07/2020 - 11/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 11/2023
2	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2022
2	Infections 11/2020 - 04/2019
2	Chronic Hepatitis B 04/2019 - 11/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	Brain Neoplasms (Brain Tumor) 06/2023
1	Glioblastoma (Glioblastoma Multiforme) 06/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Inflammation (Inflammations) 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Obesity 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019
1	Fibrosis (Cirrhosis) 04/2019
1	Bacterial Infections (Bacterial Infection) 08/2017

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 07/2023 - 07/2020
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2018
3	NivolumabIBA 01/2024 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2022
3	CytokinesIBA 03/2022 - 01/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 08/2017
2	Gemcitabine FDA Link 01/2024 - 11/2023
2	Carrier Proteins (Binding Protein)IBA 04/2019 - 11/2018
1	Cetuximab (Erbitux)FDA Link 12/2023
1	satraplatin (JM 216)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	PlatinumIBA 01/2023
1	abirateroneIBA 01/2022
1	enzalutamideIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	AndrogensIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Everolimus FDA Link 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	Therapeutic UsesIBA 11/2021
1	C 325IBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2021
1	Angiotensin Receptor AntagonistsIBA 10/2021
1	AntacidsIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Cytidine Triphosphate (CTP)IBA 07/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Glycoproteins (Glycoprotein)IBA 04/2019

Therapy/Procedure

13	Therapeutics 05/2023 - 11/2018
7	Immunotherapy 12/2021 - 07/2020
2	Organ Sparing Treatments 01/2024 - 11/2023
2	Castration 01/2023 - 01/2022
1	Cystectomy 11/2023
1	Precision Medicine 01/2022
1	Treatment Delay 10/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Investigational Therapies (Experimental Therapy) 11/2020